Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 213

Results For "SEC"

3007 News Found

QIAGEN selects TCS for cloud transformation strategy
Digitisation | June 16, 2022

QIAGEN selects TCS for cloud transformation strategy

QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth


Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions
Supply Chain | June 15, 2022

Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions

Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals


NHA and NASSCOM organised a conclave on Ayushman Bharat Digital Mission
Policy | June 15, 2022

NHA and NASSCOM organised a conclave on Ayushman Bharat Digital Mission

The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem


COVID is not over yet, says Union Health Minister
Policy | June 14, 2022

COVID is not over yet, says Union Health Minister

Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community


Philips announces positive research results from its TOBA II BTK clinical trial
Clinical Trials | June 14, 2022

Philips announces positive research results from its TOBA II BTK clinical trial

First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization


FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer
Drug Approval | June 14, 2022

FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer

Acceptance based on results from the phase 3 KEYNOTE-091 trial


Cantourage and Clever leaves intensify partnership for distribution of medical cannabis in Germany
News | June 12, 2022

Cantourage and Clever leaves intensify partnership for distribution of medical cannabis in Germany

Cantourage introduces second Clever Leaves medical cannabis product to the German market


Quizartinib Plus chemotherapy significantly improved overall survival compared to chemo
News | June 12, 2022

Quizartinib Plus chemotherapy significantly improved overall survival compared to chemo

Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium


Strides receives USFDA approval for Ibuprofen OTC oral suspension
Drug Approval | June 12, 2022

Strides receives USFDA approval for Ibuprofen OTC oral suspension

Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.


Isotopia and CPDC deliver first doses of n.c.a. Lu-177 to North American customers
News | June 12, 2022

Isotopia and CPDC deliver first doses of n.c.a. Lu-177 to North American customers

The production and supply in Canada are designed to address the growing need for no-carrier-added Lutetium-177 (n.c.a. Lu-177) in North America